Geographic barriers to gynecologic oncology care affects nearly 10% of women
the ONA take:
Access to specialty care for gynecologic cancers is limited in a significant portion of the country, according to a recent study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
The study reveals that 47 states have at least one county located more than 50 miles from the nearest gynecologic oncologist.
The researchers estimate than more than 7,000 women with gynecologic cancers experience distance-related barriers to specialist care.
In addition, referral network-related barriers affect access to specialist care for 15% of women. The study showed that 123 referral networks nationally do not have access to a gynecologic oncologist, and women have to travel outside of the referral network to be connected to a specialist.
The impact limited access to high-quality care has on clinical outcomes is not yet known. The researchers suggest future studies should focus on correlating poor clinical outcomes with geographic factors.
Access to specialty care for gynecologic cancers is limited in a significant portion of the country.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- ONS Partners with ASCO CancerLinQ to Launch CancerLinQ® Ambassadors Program
- Characteristics of Clinical Trials and Barriers to Patient Enrollment Identified
- Exercise Improves Coping While Undergoing Chemotherapy for Advanced GI Cancer
- Genetic Similarity to BRCA1/BRCA2 Mutations May Impact Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|